Egetis Therapeutics AB (P0F) Q2 2024 Earnings Report
DE:P0F Q2 2024 EPS Results
- Actual EPS
- -EUR 0.02
- Consensus EPS
- -EUR 0.03
- Beat/Miss
- Beat by +EUR 0.01
- One Year Ago EPS
- -EUR 0.03
DE:P0F Q2 2024 Revenue Results
- Actual Revenue
- EUR 1.26M
- Expected Revenue
- EUR 1.06M
- Beat/Miss
- Beat by +EUR 204.34K
- YoY Revenue Growth
- +135.59%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/22/2024
- Time
- Before Open
- Conference Call
- Thursday, August 22, 2024
DE:P0F Upcoming Earnings
Egetis Therapeutics AB's next earnings date is estimated for November 6, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:P0F Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 06, 2026 | 2026 (Q3) | -0.02- | -0.02 | ― | ― |
| Aug 21, 2026 | 2026 (Q2) | -0.01-0.02 | -0.02 | -17.62% (-0.00) | |
| Apr 29, 2026 | 2026 (Q1) | -0.02-0.02 | -0.02 | -41.18% (-0.01) | |
| Feb 26, 2026 | 2025 (Q4) | -0.02-0.03 | -0.03 | 2.58% (+0.00) | |
| Nov 25, 2025 | 2025 (Q3) | -0.02-0.02 | -0.03 | 18.73% (+0.00) | |
| Aug 21, 2025 | 2025 (Q2) | -0.02-0.02 | -0.02 | 12.13% (+0.00) | |
| Apr 30, 2025 | 2025 (Q1) | -0.02-0.02 | -0.02 | 34.62% (+0.01) | |
| Feb 26, 2025 | 2024 (Q4) | -0.02-0.03 | -0.03 | 5.20% (+0.00) | |
| Nov 08, 2024 | 2024 (Q3) | -0.03-0.03 | -0.03 | 18.21% (+0.01) | |
| Aug 22, 2024 | 2024 (Q2) | -0.03-0.02 | -0.03 | 24.84% (+0.01) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed